Skip to main content

Table 1 Clinical characteristics and glycemic control overview for patients with or without diabetesa

From: Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults

 

NON

DM

P -value

Number

2,550

747

 

Age (yr)

67 (52 to 81)

70 (60 to 80)

0.0009

Median ICU LOS (IQR)

2.3 (1.5 to 5.0)

2.4 (1.6 to 5.0)

0.3004

Mean ICU LOS (SD)

4.5 (5.8)

4.6 (5.6)

N/A

Mechanical ventilation (%)

48.20

51.94

0.0790

APS

51 (37 to 70)

60 (44 to 79)

<0.0001

APACHE IV PM (%)

19.6 (23.5)b

25.4 (25.6)c

<0.0001

Mortality (%)

12.12

15.26

0.0282

TIR

80.6 (61.4 to 94.0)

55.0 (35.3 to 71.1)

<0.0001

Median number of BG tests (IQR)

17 (9 to 36)

22 (12 to 48)

<0.0001

Mean number of tests (SD)

33.6 (45.8)

43.7 (59.1)

N/A

BG tests per 24 hr

7.47

9.50

 

Mean BG

121.4 (111.5 to 132.6)

140.3 (127.6 to 154.9)

<0.0001

CV (%)

17.6 (13.6 to 22.9)

27.3 (20.8 to 36.3)

<0.0001

Hypo <70 (% of patients)

18.04

31.46

<0.0001

Hypo <40 (% of patients)

1.37

2.81

0.0118

  1. aData are displayed as number, mean (SD), median (IQR) or percentage, as appropriate. Cardiovascular surgery patients did not have APACHE IV predicted mortality calculated. APACHE, Acute Physiology and Chronic Health Evaluation; APS, Acute Physiology Score component of the APACHE IV predicted mortality severity scoring system; BG, Blood glucose; CV, Coefficient of variation; DM, Diabetes mellitus group; Hypo, Hypoglycemia; ICU, Intensive care unit; IQR, Interquartile range; LOS, Length of stay; N/A, Not appropriate; NON, Non-diabetic group; PM, Predicted mortality; SD, Standard deviation; TIR, Time in targeted blood glucose range. bn =2,320. cn =684.